Document is current
Any future updates will be listed below
-
Authors
Mellet, Juanita
Hendricks, Candice L.
Stivaktas, Voula
Durandt, Chrisna
Ambele, Melvin A.
Pepper, Michael S. https://orcid.org/0000-0001-6406-2380
-
Funding
Funding for this research was provided by:
South African Medical Research Council (SAMRC-RFA-UFSP-01-2013/STEM CELLS)
Institute for Cellular and Molecular Medicine, University of Pretoria (Institute for Cellular and Molecular Medicine, University of Pretoria)
- License Information
-
More Information
Article History
Received: 29 February 2024
Accepted: 25 August 2024
First Online: 20 September 2024
Declarations
:
: This study was conducted at the Institute for Cellular and Molecular Medicine (ICMM), Department of Immunology, University of Pretoria. Approval was granted for two projects titled “Hematopoietic stem and progenitor cell heterogeneity and susceptibility to HIV-1” in 2014 and “Characterisation of umbilical cord blood derived haematopoietic stem and progenitor cells from HIV exposed infants that are HIV negative at birth” in 2020 by the Faculty of Health Sciences Research Ethics Committee. The protocol numbers are 410/2014 (30 October 2014) and 102/2020 (28 July 2020), respectively. Additionally, approval was obtained from the Research Operations Committee of the private hospital group concerned with the approval numbers UNIV-2014-0058 and UNIV-2021-0007.
: Not applicable.
: The authors declare the following: Michael S. Pepper has received research grant funding from the South African Medical Research Council, the Bill and Melinda Gates Foundation, the South African National Research Foundation and the National Health Laboratory Service Research Trust, and the Wellcome Trust. He is a co-founder and non-remunerated Board Member of Antion Biosciences. Candice L. Hendricks is a non-remunerated board member of DKMS Africa, a not-for-profit organisation. The authors used products/services from a commercial company that Voula Stivaktas is affiliated with (Beckman Coulter).
